Interrelation of Hypoxia-Inducible Factor-1 Alpha (HIF-1 a) and the Ratio between the Mean Corpuscular Volume/Lymphocytes (MCVL) and the Cumulative Inflammatory Index (IIC) in Ulcerative Colitis
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Poenariu, Ioan Sabin
- Boldeanu, Lidia
- Ungureanu, Bogdan Silviu
- Caragea, Daniel Cosmin
- Cristea, Oana Mariana
- Padureanu, Vlad
- Silosi, Isabela
- Ungureanu, Anca Marinela
- Statie, Razvan-Cristian
- Ciobanu, Alina Elena
- Gheonea, Dan Ionut
- Osiac, Eugen
- Boldeanu, Mihail Virgil
- Estevinho, Maria Manuela
Unidades de investigação
Abstract
We intended to investigate the presence and medical application of serum hypoxia-inducible factor-1 alpha (HIF-1 alpha) along with the already known systemic inflammatory markers and the new one's inflammatory indices, the proportion of mean corpuscular volume and lymphocytes (MCVL) and the cumulative inflammatory index (IIC), for patients with ulcerative colitis (UC). We sought to establish correlations that may be present between the serum levels of HIF-1 alpha and these inflammatory indices, as well as their relationship with disease activity and the extent of UC, which can provide us with a more precise understanding of the evolution, prognosis, and future well-being of patients. Serum samples were collected from 46 patients diagnosed with UC and 23 controls. For our assessment of the serum levels of HIF-1 alpha, we used the Enzyme-Linked Immunosorbent Assay (ELISA) technique. Thus, for HIF-1 alpha we detected significantly higher values in more severe and more extensive UC. When it came to MCVL and IIC, we observed statistically significant differences between the three groups being compared (Severe, Moderate, and Mild). Our study highlighted that HIF-1 alpha correlated much better with a disease activity score, MCVL, and IIC. With MCVL and IIC, a strong and very strong correlation had formed between them and well-known inflammation indices. By examining the ROC curves of the analyzed parameters, we recognized that TWI (accuracy of 83.70%) provides the best discrimination of patients with early forms of UC, followed by HIF-1 alpha (73.90% accuracy), MCVL (70.90% accuracy), and PLR (70.40%). In our study, we observed that HIF-1 alpha, MCVL, and PLR had the same sensitivity (73.33%) but HIF-1 alpha had a much better specificity (60.87% vs. 58.70%, and 54.35%). Also, in addition to the PLR, HIF-1 alpha and MCVL can be used as independent predictor factors in the discrimination of patients with early forms of UC.
Dados da publicação
- ISSN/ISSNe:
- 2227-9059, 2227-9059
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 38137357
Biomedicines MDPI AG
Citações Recebidas na Web of Science: 7
Documentos
- Não há documentos
Filiações
Keywords
- ulcerative colitis; hypoxia-inducible factor-1 alpha; IIC; cumulative inflammatory index; MCVL; average crepuscular volume-lymphocyte ratio; hematologic markers
Projetos associados
Gut microbiome and IBD therapy: an interplay?
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (GutIBD) . 2021
Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (IronIBD) . 2021
Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (4WARD) . 2021
Isolated Ulceration of Crohn’s Anastomosis
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2022
Burden of Inflammatory Bowel Disease in Portugal
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico (Inflammatory Bowel) . 2023
Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2019
Citar a publicação
Poenariu IS,Boldeanu L,Ungureanu BS,Caragea DC,Cristea OM,Padureanu V,Silosi I,Ungureanu AM,Statie R,Ciobanu AE,Gheonea DI,Osiac E,Boldeanu MV,Magro F,Estevinho MM. Interrelation of Hypoxia-Inducible Factor-1 Alpha (HIF-1 a) and the Ratio between the Mean Corpuscular Volume/Lymphocytes (MCVL) and the Cumulative Inflammatory Index (IIC) in Ulcerative Colitis. Biomedicines. 2023. 11. (12):3137. IF:4,700. (1).
Portal de investigação
